NCT00557960

ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

A Phase IIIb Study to Evaluate the Efficacy and Time Course of Treatment With ADDERALL XR and STRATTERA Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With Attention Deficit Hyperactivity Disorder (ADHD)

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 36 (actual)
• Sponsor: Shire · Industry
• Sex: All
• Age: 19 Years – 25 Years
• Healthy volunteers: Not accepted

Summary

Evaluate the efficacy of treatment with ADDERALL XR and STRATTERA compared to placebo on simulated driving safety and performance of young adults with ADHD as measured by Driving Safety Scores derived by the Driving Simulator.

Conditions

• Attention Deficit Disorder With Hyperactivity

Interventions

Type	Name	Description
DRUG	Mixed salts of a single-entity amphetamine
DRUG	Atomoxetine hydrochloride

Timeline

• Start date: 2004-02-25
• Primary completion: 2004-10-25
• Completion: 2004-10-25
• First posted: 2007-11-14
• Last updated: 2021-05-25

Locations

1 site across 1 country: United States